Foghorn Therapeutics Inc.

SEC 4 · Filed

0001831755-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jan 30, 2026

Grant, award or other acquisition by LaCascia Michael

Security
Stock option (right to buy)
Code
A
Shares
295,000
Price per share
5.71
Structured facts
{
  "code": "A",
  "date": "2026-01-30",
  "direction": "A",
  "exercise_price": "5.71",
  "expiration": "2036-01-29",
  "footnotes": {
    "F1": "The option vests as to 25% of the underlying shares of common stock on January 30, 2027, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."
  },
  "owners": [
    {
      "cik": "0001831755",
      "name": "LaCascia Michael",
      "roles": [
        "officer"
      ],
      "title": "Chief Legal Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "295000.00",
  "price": "5.71",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Stock option (right to buy)",
  "shares": "295000.00",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "295000.00"
}